In a regulatory filing, Gossamer Bio disclosed that its CEO Faheem Hasnain bought 878.6K shares of common stock on March 20th as part of option exercise in a total transaction size of $1.0M. Shares of Gossamer Bio are up 11% afterhours at $1.23.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on GOSS:
- Gossamer Bio price target lowered to $1.50 from $2 at Barclays
- Gossamer Bio options imply 16.5% move in share price post-earnings
- Gossamer Bio reports Q4 EPS (59c), consensus (62c)
- Gossamer Bio options imply 6.3% move in share price post-earnings
- Gossamer Bio options imply 36.4% move in share price post-earnings
